Brain CancerFeaturedNeurology·November 27, 2017·7 min readCancer Drug Starts Clinical Trials in Human Brain Cancer PatientsA new drug has been cleared for human trials in patients with anaplastic astrocytoma and glioblastoma brain cancers. The drug, PAC-1, is reported to spur cancer cells to self destruct and has proven to be effective in animal models of brain cancers.Read More